EDITORIAL SECTION

  • STRATEGY

    Smarter Pharma

    Quality management systems QMS are the backbone of pharmaceutical manufacturing ensuring safe products

  • EXPERT Talk

    Compliance to Competitive Advantage in Pharma Supply

    Compliance gets you through an audit Resilience gets medicines to patients on the day something unexpected happens The DSCSAs enhanced requirements took effect November but real interoperability required three more rounds of accommodation phased implementation with the smalldispenser

KNOWLEDGE BANK

  • Articles

    The Role of Robotics and AI in Pharmaceutical Automation

    The pharmaceutical industry experiences a revolutionary change while speed precision and safety remain vital in the current times What is pharmaceutical automation The integration of robotics in pharmacy and artificial intelligence AI functions as technology to streamline all pharmaceutical processes starting from drug development through distribution The innovations in pharmaceutical practice pre...

    The Impact of Inflation and New Policies on Drug Pricing

    Drug pricing has long been a contentious issue balancing the cost of innovation and the need for accessible healthcare In recent years the landscape has grown more complex due to rising inflation

    Patient-Centered Approaches In Pharma: From R&D to the Future

    The pharmaceutical industry is undergoing a paradigm shift towards patientcentered approaches recognizing the importance of considering patient perspectives throughout the drug development and healthcare delivery process

    The Unprecedented Surge of Biopharmaceuticals in the European Market

    Recent years have seen a significant upheaval in the European pharmaceutical scene marked by an unparalleled surge in biopharmaceutical prominence This shift isnt fleeting but signifies a profound and enduring transformation To fully grasp this paradigm shift its essential to explore the complex interplay of scientific advancements market dynamics regulatory frameworks economic factors and global...

    B2B Pharma Webinars: Driving Regulatory Insights for Decision-Makers

    The regulatory intelligence in the modern dynamic pharmaceutical ecosystem cannot be just an office role any longer it is a strategic necessity With the changing world guidelines and digital transformation reallife evidences needed and crossborder compliance frameworks the decisionmakers have to keep pace with the incessant change in regulations

    Understanding Pharmacodynamics: The Science behind Drug Action Mechanisms

    In the complicated world of pharmacology pharmacodynamics is also a place that is a bridge between chemistry and physiology Drugs do something somewhere and this explains how they do it In a simple way pharmacodynamics studies the action of drugs the effects of drugs in terms of their biochemical and physiological effects and how the effects are generated

TOP ARTICLES

  • 1

    The Impact of Inflation and New Policies on Drug Pricing

    Kate Williamson

    This article explores the intricate relationship between inflation, new policies, and drug pricing in the pharmaceutical industry. It delves into the mechanisms of inflation affecting raw materials, l...

press releases Read more...

PannTheraPi Receives ANSM Approval to Advance PTI5803 into Phase 2a in Focal Cortical Dysplasia

PannTheraPi a clinicalstage biopharmaceutical company developing innovative treatments for neurological diseases by selectively targeting the pannexin Panx channel today announces approval by the French

Bristol Myers Squibb Announces Positive Topline Results from Registrational Phase 2 QUINTESSENTIAL Trial of the Potential First-in-Class GPRC5D-Directed CAR T Cell Therapy, Arlocabtagene Autoleucel ...

Bristol Myers Squibb NYSE BMY today announced positive Phase results from the registrational QUINTESSENTIAL trial NCT of arlocabtagene autoleucel arlocel BMS in adult patients

Ionis partner Novartis announces Lp(a)HORIZON Phase 3 topline results for pelacarsen in patients with elevated Lp(a) and established cardiovascular disease (CVD)

Ionis Pharmaceuticals Inc Nasdaq IONS partner Novartis today announced that the pelacarsen Phase LpaHORIZON study a pioneering cardiovascular outcomes trial did not meet its primary endpoint

Novartis announces Lp(a)HORIZON Phase III topline results for pelacarsen in patients with elevated Lp(a) and established cardiovascular disease (CVD)

Novartis today announced that the pelacarsen phase III LpaHORIZON trial a pioneering cardiovascular outcomes study did not meet its primary endpoint of reducing the risk of cardiovascular events a composite

14 - 15

Sep 2026

16th American DDF Summit

Omni Boston Hotel at the Seapo...

15 - 17

Sep 2026

COPD Drug Development Summit 2026

Street, Boston, MA 02210, USA

21 - 23

Sep 2026

21 - 23

Sep 2026

Cancer R&D World Conference

Hilton Garden Inn Miami Dolphi...

22 - 23

Sep 2026

22 - 24

Sep 2026

28 - 01

Sep 2026

LATEST NEWS Read more...

HCW Biologics Signs Exclusive Distribution Agreement with Akron Biotech for HCW11-006

HCW Biologics Inc a USbased clinicalstage biopharmaceutical company has entered into an exclusive distribution agreement with Akron Biotech to commercialise HCW as a reagent for producing highly functional human CART cells

Sernova and Seraxis to Merge and Form BetaNova Biotherapeutics for Type 1 Diabetes Cell Replacement

Sernova Biotherapeutics Inc and Seraxis Holdings Inc have entered into a definitive merger agreement to combine their technologies and create BetaNova Biotherapeutics a clinicalstage biotechnology

AtomVie opens new radiopharmaceutical manufacturing facility in Ontario

AtomVie Global Radiopharma AtomVie has opened a new purposebuilt radiopharmaceutical manufacturing facility in Hamilton Ontario strengthening its capacity to support drug development and commercial production

Acepodia receives FDA clearance for ACE723 antibody-drug conjugate

Acepodia a clinicalstage biotechnology company developing cell therapies and antibodydrug conjugates ADCs has received clearance from the US Food and Drug Administration FDA for its Investigational New Drug IND application for ACE

Kali Therapeutics Receives U.S. FDA Clearance for KT501 Clinical Trial

Kali Therapeutics a clinicalstage biotechnology company developing immuneresetting and multispecific therapies has received clearance from the US Food and Drug Administration FDA for its Investigational New

Abcam and Genedata Collaborate to Accelerate AI-Driven Antibody Development

Genedata has expanded its collaboration with Abcam to strengthen antibody development and support the use of artificial intelligence AI across Abcams global research and development operations